ClinicalTrials.Veeva

Menu

Advancing Prevention of Pulmonary Fibrosis (APPLe)

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Active, not recruiting

Conditions

Pulmonary Fibrosis
IPF
ILD

Treatments

Other: Questionnaires
Diagnostic Test: Pulmonary Function Test
Radiation: High resolution CT scan of the chest
Other: Sample collection

Study type

Observational

Funder types

Other

Identifiers

NCT04564183
20-1739

Details and patient eligibility

About

This study plans to learn more about pulmonary fibrosis and how it develops. We want to determine if the disease can be detected early, before the lung is permanently scarred.

This study will enroll participants who are not currently diagnosed with pulmonary fibrosis, but who have family members with pulmonary fibrosis. Because there is an increased risk within affected families, this cohort will allow us to learn how pulmonary fibrosis develops, and how the lungs change over time.

Enrollment

800 estimated patients

Sex

All

Ages

40 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Unaffected first degree relative from Familial Interstitial Pneumonia families (two or more family members with IIP)
  • Age at least 40 years old and younger than 75 years old

Exclusion criteria

  • Diagnosed with known (physician-diagnosed) pulmonary fibrosis prior to informed consent
  • Other genetic diseases associated with interstitial lung disease
  • Pregnant women

Trial design

800 participants in 1 patient group

Full Cohort
Description:
Entire study population
Treatment:
Other: Sample collection
Radiation: High resolution CT scan of the chest
Diagnostic Test: Pulmonary Function Test
Other: Questionnaires

Trial contacts and locations

1

Loading...

Central trial contact

Rachel Warren; Emily Culbertson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems